Related Experiment Video
Updated: Jun 24, 2025
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Molecular Imaging in Gynecology: Beyond Cancer
Joni Sebastiano1,2,3, Cindy Rodriguez1,2,4, Zachary V Samuels1,2,4
1Department of Chemistry, Hunter College, City University of New York, New York, New York.
Abstract:
Gynecological pathologies account for approximately 4.5% of the overall global disease burden. Although cancers of the female reproductive system have understandably been the focus of a great deal of research, benign gynecological conditions-such as endometriosis, polycystic ovary syndrome, and uterine fibroids-have remained stubbornly understudied despite their astonishing ubiquity and grave morbidity. This historical inattention has frequently become manifested in flawed diagnostic and treatment paradigms. Molecular imaging could be instrumental in improving patient care on both fronts. In this Focus on Molecular Imaging review, we will examine recent advances in the use of PET, SPECT, MRI, and fluorescence imaging for the diagnosis and management of benign gynecological conditions, with particular emphasis on recent clinical reports, areas of need, and opportunities for growth.
Insights
Benign gynecological conditions are understudied, leading to flawed diagnostics and treatments. Molecular imaging offers a promising approach to improve diagnosis and management of these common conditions.
Area of Science:
- Gynecology
- Medical Imaging
- Pathology
Background:
- Benign gynecological conditions like endometriosis, PCOS, and fibroids are common but understudied.
- This lack of research has led to suboptimal diagnostic and treatment strategies.
- These conditions significantly impact global health and patient morbidity.
Purpose of the Study:
- To review recent advances in molecular imaging for benign gynecological conditions.
- To highlight the role of PET, SPECT, MRI, and fluorescence imaging.
- To identify areas of need and opportunities for future growth in the field.
Main Methods:
- Review of recent clinical reports and advancements in molecular imaging techniques.
- Focus on Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT), Magnetic Resonance Imaging (MRI), and fluorescence imaging.
- Analysis of current diagnostic and management paradigms.
Main Results:
- Molecular imaging shows potential for improving diagnosis and management of benign gynecological diseases.
- PET, SPECT, MRI, and fluorescence imaging are key modalities being explored.
- Current approaches reveal gaps in understanding and treatment efficacy.
Conclusions:
- Molecular imaging is crucial for advancing the care of patients with benign gynecological pathologies.
- Further research and clinical application of these techniques are warranted.
- Addressing the understudied nature of these conditions through advanced imaging is a key opportunity.
